Related Experiment Video
Updated: Aug 8, 2026

Adenovirus-mediated Genetic Removal of Signaling Molecules in Cultured Primary Mouse Embryonic Fibroblasts
Published on: September 10, 2010
[Decrease in the transforming action of Rous sarcoma virus produced by avian cells grown in the presence of
Abstract:
Treatment of Rous Sarcoma virus transformed chick embryo fibroblasts with 1 mM 5'-deoxy-5'-S-isobutyladenosine for 24 hrs. leads to the inhibition of transforming virus production. A kinetic analysis of the inhibition of active virion production revealed that the effect of the drug was time and concentration dependent. After 24 hrs. with 1 mM SIBA, the production of transforming virus was inhibited 165 fold. However, under these conditions there was only a 2 fold inhibition in viral particle production. Thus, these viral particles were either non infective (non adsorbed on cell membrane) or non transforming. The majority of viral particles produced by cells cultured with the drug have a decreased density. Analysis of these virions showed a decrease of protein P19 and an accumulation of proteins with high molecular weight.
Insights
The drug 5'-deoxy-5'-S-isobutyladenosine (SIBA) significantly inhibits Rous Sarcoma virus production in chick cells. SIBA treatment yields non-infective viral particles, impacting viral transformation and replication.
Area of Science:
- Virology
- Molecular Biology
- Cell Biology
Context:
- Rous Sarcoma virus (RSV) is a retrovirus that causes tumors in chickens.
- Chick embryo fibroblasts are commonly used model systems for studying viral replication and transformation.
- 5'-deoxy-5'-S-isobutyladenosine (SIBA) is an adenosine analog with potential antiviral properties.
Purpose:
- To investigate the effect of SIBA on Rous Sarcoma virus production and virion characteristics.
- To determine the mechanism by which SIBA inhibits viral replication.
Summary:
- Treatment of RSV-transformed chick embryo fibroblasts with 1 mM SIBA for 24 hours resulted in a 165-fold inhibition of transforming virus production.
- Viral particle production was only inhibited 2-fold, indicating the produced virions were non-infective or non-transforming.
- SIBA treatment led to decreased virion density, reduced levels of protein P19, and accumulation of high molecular weight proteins.
Impact:
- SIBA effectively inhibits the production of infectious and transforming Rous Sarcoma virus.
- The drug alters virion composition, suggesting a disruption in viral assembly or maturation.
- These findings provide insights into potential therapeutic strategies targeting viral replication and transformation.
Related Concept Videos
Experimental RNAi
Mechanisms of Retrovirus-induced Cancers
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

